Current Approaches to the Treatment of Hunter Syndrome

Mucopolysaccharidosis type II (MPS II; Hunter syndrome) is an X-linked hereditary disorder associated with a deficiency of iduronate2-sulfatase (IDS). IDS deficiency provokes the accumulation of dermatan sulfate and heparan sulfate in different tissues. Clinical manifestations of MPS II are heteroge...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ekaterina Yu. Zakharova, Elena Yu. Voskoboeva, Alla N. Semyachkina, Nato D. Vashakmadze, Amina I. Gamzatova, Svetlana V. Mikhailova, Sergey I. Kutsev
Formato: Artigo
Idioma:Inglês
Publicado em: Paediatrician Publishers, LLC 2018-10-01
Colecção:Pediatričeskaâ Farmakologiâ
Assuntos:
hunter syndrome
mucopolysaccharidosis type ii
enzyme replacement therapy
gene therapy
hematopoietic stem cell transplantation
Acesso em linha:https://www.pedpharma.ru/jour/article/view/1653
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados